SXSiqi Xu

Siqi Xu

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Siqi Xu has a total of 37 co-authors. Here are the top co-authors by number of shared publications:

  • Changhai Ding

    Clinical Research Centre, Zhujiang Hospital Southern Medical University Guangzhou Guangdong China

    2 shared publications
  • Guangfeng Ruan

    Clinical Research Centre, Guangzhou First People’s Hospital, South China University of Technology, Guangzhou, China

    2 shared publications
  • Jianwei Zhu

    Department of Orthopedics, School of Medicine The Second Affiliated Hospital of South China University of Technology (Guangzhou First People's Hospital) Guangzhou Guangdong China

    2 shared publications
  • Simin Wen

    Department of Orthopedics, Guangzhou First People's Hospital Guangzhou Medical University Guangzhou China

    2 shared publications
  • Xizeng Zong

    Clinical Research Centre, School of Medicine The Second Affiliated Hospital of South China University of Technology (Guangzhou First People's Hospital) Guangzhou Guangdong China

    2 shared publications
  • Chenxi Xie

    Department of Biostatistics, School of Public Health (State Key Laboratory of Multi-Organ Injury Prevention and Treatment, and Guangdong Provincial Key Laboratory of Tropical Disease Research), Southern Medical University, Guangzhou 510515, China

    1 shared publication

Latest Publications

  • Open Access

    Integrative Analysis Uncover the Effects and Multi‐Omics Features of Thigh Muscle Fat Infiltration

    by Yiwei Zhang, Qin Dang, Xizeng Zong, Haowei Chen, Simin Wen, Siqi Xu, Kunyan Wang, Xiaoshuai Wang, Jianwei Zhu, Zhaohua Zhu, et al.

    The health impacts and underlying biological pathways of thigh muscle fat infiltration (TMFI) remain incompletely understood. In this study, we analyzed TMFI measured by magnetic resonance imaging in 55,120 UK Biobank participants and found that higher TMFI was significantly associated with all‐cause mortality as well as with all major system‐specific diseases examined ( p values ranged from 2.50 × 10 −88 to 9.97 × 10 −04 ). TMFI also mediated the effects of lifestyle factors on health‐related outcomes, with mediation proportions ranging from 6.7% to 71.7%. A genome‐wide association study (GWAS) identified 79 lead single nucleotide polymorphisms (SNPs) linked to TMFI, and the polygenic risk score for TMFI was significantly associated with mortality and all incident diseases across examined organ systems in an independent subset of UK Biobank participants of European ancestry who were not included in the TMFI GWAS ( n = 362,286, all p < 0.05). Gene–drug interactions identified multiple drugs that could potentially modulate TMFI. Analysis of single‐cell transcriptomic data indicated that myogenic cells were strongly linked to TMFI ( p = 7.08 × 10 −08 ). Summary‐data‐based Mendelian randomization and Transcriptome‐Wide Association Study analyses revealed numerous genes whose expression in specific tissues was associated with TMFI. Proteomic and metabolomic profiling uncovered a broad array of circulating biomarkers associated with TMFI, many of which mediated the effects of modifiable factors and genetic risk on TMFI. Overall, our results highlight the biological relevance of TMFI to human health and provide insights into the multi‐omics mechanisms underlying TMFI, identifying potential targets for interventions.

  • Open Access

    Integrated Single-Cell and Spatial Transcriptomics Analyses Delineate a BAG3-Associated Macrophage Program with Microenvironmental and Prognostic Relevance in Hepatocellular Carcinoma

    by Ruixiang Zhang, Yifang Wei, Junda Yu, Yuansheng Li, Zuming You, Chenxi Xie, Siqi Xu, Jiyuan Zhou

    Background: Tumor-associated macrophages (TAMs) are key components of the hepatocellular carcinoma (HCC) microenvironment, but their spatial heterogeneity remains incompletely characterized. We aimed to assess the biological and prognostic relevance of a BAG3-associated TAM program in HCC. Methods: Public single-cell RNA sequencing (scRNA-seq) datasets were analyzed to characterize TAM heterogeneity, and an integrated validation scRNA-seq dataset was used to assess reproducibility. Spatial transcriptomics was used to provide spatial context in a small treatment-exposed cohort. Pseudotime, regulatory network, and cell–cell communication analyses were performed to characterize state transitions and microenvironmental interactions. Survival modeling evaluated the prognostic relevance of the BAG3-associated program. Results: Five TAM subsets were identified, including MARCO+, MT+ RTM−, MMP9+, UBE2C+, and BAG3+ TAMs. Among them, BAG3+ TAMs, a less well-characterized subset, exhibited coordinated stress-adaptive, proteostasis-related, and matrix-remodeling programs that were reproduced in the validation dataset. Pseudotime analysis suggested a continuum of TAM states, with BAG3+ TAM stress-remodeling features enriched toward late pseudotime. Communication analysis centered on BAG3+ TAMs suggested crosstalk between inflammatory stress cues and angiogenic, stromal-remodeling, and immunomodulatory programs; this pattern was primarily supported by HBV-derived samples and recurrently involved the MIF–CD74 axis. Spatial mapping further supported BAG3+ TAM-enriched niches with elevated AP-1, EGR1, and NFKB1 activity. A BAG3-associated risk score derived from a 10-gene signature remained an independent prognostic factor for overall survival after clinical adjustment. Conclusions: These findings characterize a BAG3-associated TAM program with spatial, immunoregulatory, and prognostic relevance in HCC, and support its further evaluation in biomarker and mechanistic studies.


  • Subchondral bone density and trabecular morphometry mediate the association between knee malalignment and osteophyte progression in osteoarthritis: data from the osteoarthritis initiative

    by Shiwen Yuan, Guangfeng Ruan, Xiaodong Wang, Grace H. Lo, Cuicui Wang, Zhaohua Zhu, Siqi Xu, Weinian Li, Xiaoyan Cai, David J. Hunter

    Objective To investigate whether subchondral bone mediates the relationship between knee malalignment and osteophyte progression. Design Data were obtained from the Osteoarthritis Initiative (OAI) and two ancillary imaging studies. Two analytic cohorts were defined by mediator type: a DXA cohort (periarticular bone mineral density [paBMD]) and an MRI cohort (trabecular morphometry: aBVF, aTb.N, aTb.Sp, aTb.Th). Alignment (hip–knee–ankle [HKA] angle) was assessed at either 12 or 24 months under the Lower Limb Alignment study; bone measures were obtained at either 30 or 36 months through the Bone Ancillary Study; and radiographic osteophyte scores were evaluated at baseline and 48 months. Knees were categorized into five alignment groups (neutral, mild/severe varus, mild/severe valgus). Analyses used generalized estimating equations and multivariable linear regression with non-parametric bootstrapping. Results A total of 826 knees (DXA cohort) [ (mean age 61.9 years (SD 9.1), BMI 29.8 kg/m2 (SD 4.5); 60.5% female; 79.8% KL grade ≥ 2)] and 401 knees (MRI cohort) were analyzed. Only severe varus and valgus were associated with osteophyte progression. For severe varus, medial progression was mediated by higher medial paBMD and a higher medial-to-lateral (M:L) paBMD ratio, accounting for 20.3% and 70.7% of the total effect for the femur, and 23.2% and 65.4% for the tibia. Medial trabecular morphometry contributed to medial tibial progression, with indirect effects via higher aBVF (27.2%) and aTb.N (35.4%), and via lower aTb.Sp (12.2%). For severe valgus, lateral progression was mediated by higher lateral paBMD and a lower M:L paBMD ratio, accounting for 14.2% and 67.9% for the femur, and 9.3% and 40.7% for the tibia. Conclusions Compartment-specific bone measures partly mediate the association between static malalignment and osteophyte progression, suggesting that targeting bone may modify this longitudinal relationship. Key Points • Compartment-specific paBMD mediates the relationship between malalignment and osteophyte progression, with the M:L BMD ratio strengthening this effect more than either medial or lateral paBMD alone. • Medial trabecular morphometry partially mediates the varus alignment-osteophyte progression relationship. • Subchondral bone remodeling is locally driven by mechanical stress, as systemic measures like femoral neck BMD do not mediate the malalignment-osteophyte link.


  • Identification of Circulating Proteins Associated With Blood Pressure

    by Siqi Xu, Simin Wen, Xizeng Zong, Shifeng Wen, Jianwei Zhu, Weipeng Zheng, Zhiqiang Wang, Peihua Cao, Zhijiang Liang, Changhai Ding, et al.

    BACKGROUND: Circulating proteins in blood are involved in various physiological processes, but their contributions to blood pressure regulation remain partially understood. In traditional observational studies, identifying circulating proteins causally associated with blood pressure is challenging because of potentially unmeasured confounding and possible reverse causality. METHODS: Two-sample Mendelian randomization analyses were conducted to estimate the causal effects of 2270 circulating proteins (data sourced from 8 genome-wide association studies) on diastolic blood pressure, systolic blood pressure, and pulse pressure. Colocalization analyses were then used to investigate whether the circulating proteins and blood pressure traits shared causal genetic variants. To further verify the findings, we subsequently performed Steiger filtering analyses, annotation of protein-altering variants, assessment of overlap between protein quantitative trait loci and expression quantitative trait loci, protein-protein interaction and functional enrichment analyses, and drug target evaluation. To provide more potential biomarkers, we further evaluated the epidemiological associations of 2923 circulating proteins with blood pressure and hypertension by cross-sectional and longitudinal analyses using individual data in the UK Biobank. RESULTS: Mendelian randomization and colocalization analyses identified 121 circulating proteins with putative causal effects on at least 1 blood pressure trait. Many of the identified proteins are enriched in the pathways relevant to blood pressure regulation, and a majority of these proteins are either known drug targets or druggable candidates. CONCLUSIONS: This study has uncovered numerous circulating proteins potentially causally associated with blood pressure, providing insights into the regulatory mechanisms of blood pressure and potential therapeutic targets to facilitate blood pressure management.


  • A Novel Penalized Inverse-Variance Weighted Estimator for Mendelian Randomization with Applications to COVID-19 Outcomes

    by Siqi Xu, Peng Wang, Wing Kam Fung, Zhonghua Liu

    Mendelian randomization utilizes genetic variants as instrumental variables (IVs) to estimate the causal effect of an exposure variable on an outcome of interest even in the presence of unmeasured confounders. However, the popular inverse-variance weighted (IVW) estimator could be biased in the presence of weak IVs, a common challenge in MR studies. In this article, we develop a novel penalized inverse-variance weighted (pIVW) estimator, which adjusts the original IVW estimator to account for the weak IV issue by using a penalization approach to prevent the denominator of the pIVW estimator from being close to zero. Moreover, we adjust the variance estimation of the pIVW estimator to account for the presence of balanced horizontal pleiotropy. We show that the recently proposed debiased IVW (dIVW) estimator is a special case of our proposed pIVW estimator. We further prove that the pIVW estimator has smaller bias and variance than the dIVW estimator under some regularity conditions. We also conduct extensive simulation studies to demonstrate the performance of the proposed pIVW estimator. Furthermore, we apply the pIVW estimator to estimate the causal effects of five obesity-related exposures on three coronavirus disease 2019 (COVID-19) outcomes. Notably, we find that hypertensive disease is associated with an increased risk of hospitalized COVID-19; and peripheral vascular disease and higher body mass index are associated with increased risks of COVID-19 infection, hospitalized COVID-19, and critically ill COVID-19.